Sabril (vigabatrin) Tablet Sabril (vigabatrin) Oral Solution
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
BOXED WARNING
Additional and updated bullets:
SABRIL can cause permanent bilateral concentric visual field...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology | Warnings